DERMA SCIENCES INC's ticker is DSCI and the CUSIP is 249827502. A total of 71 filers reported holding DERMA SCIENCES INC in Q1 2014. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $663,000 | +11.6% | 127,650 | +0.3% | 0.00% | – |
| Q3 2016 | $594,000 | +18.6% | 127,298 | +0.1% | 0.00% | – |
| Q2 2016 | $501,000 | +24.9% | 127,210 | -1.9% | 0.00% | – |
| Q1 2016 | $401,000 | -41.6% | 129,697 | -13.8% | 0.00% | – |
| Q4 2015 | $687,000 | +14.5% | 150,544 | +18.1% | 0.00% | – |
| Q3 2015 | $600,000 | -35.9% | 127,471 | -2.6% | 0.00% | -100.0% |
| Q2 2015 | $936,000 | -18.4% | 130,827 | -3.5% | 0.00% | 0.0% |
| Q1 2015 | $1,147,000 | -4.1% | 135,512 | +5.5% | 0.00% | 0.0% |
| Q4 2014 | $1,196,000 | +14.1% | 128,504 | +2.1% | 0.00% | 0.0% |
| Q3 2014 | $1,048,000 | -27.0% | 125,896 | +1.4% | 0.00% | 0.0% |
| Q2 2014 | $1,435,000 | -6.9% | 124,142 | +2.1% | 0.00% | 0.0% |
| Q1 2014 | $1,542,000 | +157.9% | 121,638 | +119.8% | 0.00% | – |
| Q4 2013 | $598,000 | -11.9% | 55,350 | +1.0% | 0.00% | -100.0% |
| Q3 2013 | $679,000 | -4.2% | 54,813 | +3.2% | 0.00% | 0.0% |
| Q2 2013 | $709,000 | – | 53,110 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 507,799 | $1,574,000 | 1.86% |
| Krensavage Asset Management, LLC | 906,046 | $2,809,000 | 1.01% |
| DAFNA Capital Management LLC | 353,718 | $1,097,000 | 0.95% |
| Broadfin Capital, LLC | 2,562,104 | $7,943,000 | 0.77% |
| ROANOKE ASSET MANAGEMENT CORP/ NY | 124,549 | $386,000 | 0.18% |
| Senvest Management, LLC | 489,807 | $1,518,000 | 0.13% |
| Baker Brothers Advisors | 3,752,390 | $11,632,000 | 0.12% |
| Perceptive Advisors | 432,884 | $1,341,000 | 0.12% |
| Granahan Investment Management | 1,028,460 | $3,188,000 | 0.12% |
| Alambic Investment Management, L.P. | 49,035 | $152,000 | 0.05% |